|
1
|
Akcan-Arikan A, Zappitelli M, Loftis LL,
Washburn KK, Jefferson LS and Goldstein SL: Modified RIFLE criteria
in critically ill children with acute kidney injury. Kidney Int.
71:1028–1035. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Srisawat N, Hoste EE and Kellum JA: Modern
classification of acute kidney injury. Blood Purif. 29:300–307.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Adiyanti SS and Loho T: Acute Kidney
Injury (AKI) biomarker. Acta Med Indones. 44:246–255.
2012.PubMed/NCBI
|
|
4
|
Andreoli SP: Acute kidney injury in
children. Pediatr Nephrol. 24:253–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Memon F, Rathi SL and Memon MH: Pattern of
solid paediatric malignant neoplasm at Lumhs, Jamshoro, Pakistan. J
Ayub Med Coll Abbottabad. 19:55–57. 2007.PubMed/NCBI
|
|
6
|
Launay-Vacher V, Izzedine H, Rey JB, Rixe
O, Chapalain S, Nourdine S, Paci A, Bourget P and Deray G:
Incidence of renal insufficiency in cancer patients and evaluation
of information available on the use of anticancer drugs in renally
impaired patients. Med Sci Monit. 10:CR209–CR212. 2004.PubMed/NCBI
|
|
7
|
Kintzel PE: Anticancer drug-induced kidney
disorders. Drug Saf. 24:19–38. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Murray PT, Devarajan P, Levey AS, Eckardt
KU, Bonventre JV, Lombardi R, Herget-Rosenthal S and Levin A: A
framework and key research questions in AKI diagnosis and staging
in different environments. Clin J Am Soc Nephrol. 3:864–868. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Devarajan P: Biomarkers for the early
detection of acute kidney injury. Curr Opin Pediatr. 23:194–200.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dent CL, Ma Q, Dastrala S, Bennett M,
Mitsnefes MM, Barasch J and Devarajan P: Plasma NGAL predicts acute
kidney injury, morbidity and mortality after pediatric cardiac
surgery: A prospective uncontrolled cohort study. Crit Care.
11:R1272007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mishra J, Ma Q, Kelly C, Mitsnefes M, Mori
K, Barasch J and Devarajan P: Kidney NGAL is a novel marker of
acute injury following transplantation. Pediatr Nephrol.
21:856–863. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Parikh CR, Jani A, Mishra J, Ma Q, Kelly
C, Barasch J, Edelstein CL and Devarajan P: Urine NGAL and IL-18
are predictive biomarkers for delayed graft function following
kidney transplantation. Am J Transplant. 6:1639–1645. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trachtman H, Christen E, Cnaan A, Patrick
J, Mai V, Mishra J, Jain A, Bullington N and Devarajan P: And
Investigators of the HUS-SYNSORB Pk Multicenter Clinical Trial:
Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: A
novel marker of renal injury. Pediatr Nephrol. 21:989–994. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hirsch R, Dent C, Pfriem H, et al: NGAL is
an early predictive biomarker of contrast-induced nephropathy in
children. Pediatr Nephrol. 22:2089–2095. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du Y, Hou L, Guo J, Sun T, Wang X and Wu
Y: Renal neutrophil gelatinase-associated lipocalin and kidney
injury molecule-1 expression in children with acute kidney injury
and Henoch-Schönlein purpura nephritis. Exp Ther Med. 7:1130–1134.
2014.PubMed/NCBI
|
|
16
|
Cho E, Yang HN, Jo SK, Cho WY and Kim HK:
The role of urinary liver-type fatty acid-binding protein in
critically ill patients. J Korean Med Sci. 28:100–105. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Geus HR, Bakker J, Lesaffre EM and le
Noble JL: Neutrophil gelatinase-associated lipocalin at ICU
admission predicts for acute kidney injury in adult patients. Am J
Respir Crit Care Med. 183:907–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Christie B: Doctors revise declaration of
Helsinki. BMJ. 321:9132000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Costa e Silva VT, de Castro I, Liaño F,
Muriel A, Rodríguez-Palomares JR and Yu L: Sequential evaluation of
prognostic models in the early diagnosis of acute kidney injury in
the intensive care unit. Kidney Int. 75:982–986. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Palsson R and Niles JL: Regional citrate
anticoagulation in continuous venovenous hemofiltration in
critically ill patients with a high risk of bleeding. Kidney Int.
55:1991–1997. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Haase M and Haase-Fielitz A: Neutrophil
gelatinase-associated lipocalin for acute kidney injury - the renal
troponin. J Lab Med. 165:28–32. 2010.
|
|
22
|
Feltes CM, Van Eyk J and Rabb H:
Distant-organ changes after acute kidney injury. Nephron, Physiol.
109:80–84. 2008. View Article : Google Scholar
|
|
23
|
Lanore JJ, Brunet F, Pochard F, et al:
Hemodialysis for acute renal failure in patients with hematologic
malignancies. Crit Care Med. 19:346–351. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Benoit DD, Hoste EA, Depuydt PO, Offner
FC, Lameire NH, Vandewoude KH, Dhondt AW, Noens LA and Decruyenaere
JM: Outcome in critically ill medical patients treated with renal
replacement therapy for acute renal failure: Comparison between
patients with and those without haematological malignancies.
Nephrol Dial Transplant. 20:552–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Azoulay E, Recher C, Alberti C, Soufir L,
Leleu G, Le Gall JR, Fermand JP and Schlemmer B: Changing use of
intensive care for hematological patients: The example of multiple
myeloma. Intensive Care Med. 25:1395–1401. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Azoulay E, Moreau D, Alberti C, Leleu G,
Adrie C, Barboteu M, Cottu P, Levy V, Le Gall JR and Schlemmer B:
Predictors of short-term mortality in critically ill patients with
solid malignancies. Intensive Care Med. 26:1817–1823. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Darmon M, Thiery G, Ciroldi M, de Miranda
S, Galicier L, Raffoux E, Le Gall JR, Schlemmer B and Azoulay E:
Intensive care in patients with newly diagnosed malignancies and a
need for cancer chemotherapy. Crit Care Med. 33:2488–2493. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bagshaw SM, Laupland KB, Doig CJ, Mortis
G, Fick GH, Mucenski M, Godinez-Luna T, Svenson LW and Rosenal T:
Prognosis for long-term survival and renal recovery in critically
ill patients with severe acute renal failure: A population-based
study. Crit Care. 9:R700–R709. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mishra J, Mori K, Ma Q, Kelly C, Barasch J
and Devarajan P: Neutrophil gelatinase-associated lipocalin: A
novel early urinary biomarker for cisplatin nephrotoxicity. Am J
Nephrol. 24:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mehta RL, Kellum JA, Shah SV, Molitoris
BA, Ronco C, Warnock DG and Levin A: Acute Kidney Injury Network:
Acute Kidney Injury Network: Report of an initiative to improve
outcomes in acute kidney injury. Crit Care. 11:R312007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Waikar SS and Bonventre JV: Biomarkers for
the diagnosis of acute kidney injury. Nephron Clin Pract.
109:c192–c197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Haase M, Bellomo R, Devarajan P and
Schlattmann P: Haase-Fielitz A and NGAL Meta-analysis Investigator
Group: Accuracy of neutrophil gelatinase-associated lipocalin
(NGAL) in diagnosis and prognosis in acute kidney injury: A
systematic review and meta-analysis. Am J Kidney Dis. 54:1012–1024.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Haase-Fielitz A, Haase M and Devarajan P:
Neutrophil gelatinase-associated lipocalin as a biomarker of acute
kidney injury: A critical evaluation of current status. Ann Clin
Biochem. 51:335–351. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mishra J, Dent C, Tarabishi R, et al:
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker
for acute renal injury after cardiac surgery. Lancet.
365:1231–1238. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Parikh CR, Devarajan P, Zappitelli M, et
al: Postoperative biomarkers predict acute kidney injury and poor
outcomes after pediatric cardiac surgery. J Am Soc Nephrol.
22:1737–1747. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zappitelli M, Washburn KK, Arikan AA,
Loftis L, Ma Q, Devarajan P, Parikh CR and Goldstein SL: Urine NGAL
is an early marker of acute kidney injury in critically ill
children. Crit Care. 11:R842007. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Du Y, Zappitelli M, Mian A, Bennett M, Ma
Q, Devarajan P, Mehta R and Goldstein SL: Urinary biomarkers to
detect acute kidney injury in the pediatric emergency center.
Pediatr Nephrol. 26:267–274. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wheeler DS, Devarajan P, Ma Q, Harmon K,
Monaco M, Cvijanovich N and Wong HR: Serum neutrophil
gelatinase-associated lipocalin (NGAL) as a marker of acute kidney
injury in critically ill children with septic shock. Crit Care Med.
36:1297–1303. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Martensson J, Bell M, Oldner A, Xu S,
Venge P and Martling CR: Neutrophil gelatinase-associated lipocalin
in adult septic patients with and without acute kidney injury.
Intensiv Care Med. 36:1333–1340. 2010. View Article : Google Scholar
|
|
40
|
Nickolas TL, Schmidt-Ott KM, Canetta P, et
al: Diagnostic and prognostic stratification in the emergency
department using urinary biomarkers of nephron damage: A
multicenter prospective cohort study. J Am Coll Cardiol.
59:246–255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rahimzadeh N, Otukesh H, Hoseini R, Sorkhi
H, Otukesh M, Hoseini S and Torkzaban M: Are serum and urine
neutrophil gelatinase-associated lipocalin predictive of renal
graft function in short term. Pediatr Transplant. 16:796–802. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Royakkers AA, Bouman CS, Stassen PM,
Korevaar JC, Binnekade JM, van de Hoek W, Kuiper MA, Spronk PE and
Schultz MJ: Systemic and urinary neutrophil gelatinase-associated
lipocalins are poor predictors of acute kidney injury in unselected
critically ill patients. Crit Care Res Pract.
2012:7126952012.PubMed/NCBI
|
|
43
|
Endre ZH, Pickering JW, Walker RJ, et al:
Improved performance of urinary biomarkers of acute kidney injury
in the critically ill by stratification for injury duration and
baseline renal function. Kidney Int. 79:1119–1130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Metzger J, Kirsch T, Schiffer E, Ulger P,
Mentes E, Brand K, Weissinger EM, Haubitz M, Mischak H and
Herget-Rosenthal S: Urinary excretion of twenty peptides forms an
early and accurate diagnostic pattern of acute kidney injury.
Kidney Int. 78:1252–1262. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Daw NC, Gregornik D, Rodman J, Marina N,
Wu J, Kun LE, Jenkins JJ, McPherson V, Wilimas J and Jones DP:
Renal function after ifosfamide, carboplatin and etoposide (ICE)
chemotherapy, nephrectomy and radiotherapy in children with Wilms
tumour. Eur J Cancer. 45:99–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bailey S, Roberts A, Brock C, Price L,
Craft AW, Kilkarni R, Lee RE, Skillen AW and Skinner R:
Nephrotoxicity in survivors of Wilms' tumours in the North of
England. Br J Cancer. 87:1092–1098. 2002. View Article : Google Scholar : PubMed/NCBI
|
